A detailed history of International Biotechnology Trust PLC transactions in Relmada Therapeutics, Inc. stock. As of the latest transaction made, International Biotechnology Trust PLC holds 10,000 shares of RLMD stock, worth $3,800. This represents 0.01% of its overall portfolio holdings.

Number of Shares
10,000
Previous 10,000 -0.0%
Holding current value
$3,800
Previous $24,000 25.0%
% of portfolio
0.01%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 08, 2022

BUY
$18.3 - $37.02 $179,523 - $363,166
9,810 Added 5163.16%
10,000 $370,000
Q2 2022

Aug 16, 2022

SELL
$16.5 - $30.34 $161,865 - $297,635
-9,810 Reduced 98.1%
190 $10 Million
Q3 2021

Nov 12, 2021

BUY
$21.86 - $34.77 $218,600 - $347,700
10,000 New
10,000 $261,000

Others Institutions Holding RLMD

About RELMADA THERAPEUTICS, INC.


  • Ticker RLMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,608,500
  • Market Cap $10.9M
  • Description
  • Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a new chemical entity and N-methyl-D-aspartate receptor antagonist that ...
More about RLMD
Track This Portfolio

Track International Biotechnology Trust PLC Portfolio

Follow International Biotechnology Trust PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of International Biotechnology Trust PLC, based on Form 13F filings with the SEC.

News

Stay updated on International Biotechnology Trust PLC with notifications on news.